Patents Assigned to Moleculin Biotech, Inc.
  • Method of reconstituting liposomal annamycin
    Patent number: 11980634
    Abstract: Methods of reconstituting lyophilized Annamycin and methods of treating patients are described.
    Type: Grant
    Filed: October 5, 2023
    Date of Patent: May 14, 2024
    Assignees: Moleculin Biotech, Inc., Board of Regents, The University of Texas System
    Inventors: Donald Picker, Waldemar Priebe
  • Preparation of preliposomal annamycin lyophilizate
    Patent number: 11951118
    Abstract: Provided is a method of making a preliposomal Annamycin lyophilizate, the composition made by the method, and the use of the composition made thereby in the treatment of cancer.
    Type: Grant
    Filed: October 5, 2023
    Date of Patent: April 9, 2024
    Assignees: Moleculin Biotech, Inc., Board of Regents, The University of Texas System
    Inventors: Donald Picker, Waldemar Priebe
  • METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF
    Publication number: 20230130134
    Abstract: The present invention relates to methods of treating and preventing viral diseases and infections comprising the administration of hexoses and analogs and their prodrugs thereof that inhibit glycolysis and/or glycosylation.
    Type: Application
    Filed: March 16, 2021
    Publication date: April 27, 2023
    Applicants: Board of Regents, The University of Texas System, Moleculin Biotech, Inc.
    Inventors: Waldemar PRIEBE, Izabela FOKT, Rafal ZIELINSKI, Stanislaw SKORA, Donald PICKER, Walter KLEMP